Log in to Congenica
Please select your location and reference genome:

Latest News and Blogs

The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology

The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology

Philip Beer presented a webinar exploring one of the key challenges that we are currently facing when applying genomic testing in cancer.

The time has come to change the way we treat cancer

The time has come to change the way we treat cancer

Professor Andrew Biankin shares his experiences in transforming cancer care with genomic testing.

The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients

The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients

In recognition of Rare Disease Day, Congenica looks at the importance of a genetic diagnosis for patients and asks, what's next for rare disease?

Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute

Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute

Co-founder and Scientific Director at Congenica, Professor Matt Hurles, has today been appointed as Director of The Wellcome Trust Sanger Institute. 

What’s it like to be a woman working in science?

What’s it like to be a woman working in science?

For International Day of Women and Girls in Science, we talk to three women at Congenica about their experiences of working in STEM.

Professor Matthew Hurles discusses the Deciphering Developmental Disorders study

Professor Matthew Hurles discusses the Deciphering Developmental Disorders study

Professor Matthew Hurles, project lead for DDD study and Congenica founder, discsuses his projects, advancements in data analysis and interpretation

Congenica announces Early Access Program for its novel Precision Oncology Solution

Congenica announces Early Access Program for its novel Precision Oncology Solution

Congenica launches early access program for its new CE-IVD Precision Oncology Solution

Congenica approved as supplier on Government G-Cloud 13 framework

Congenica approved as supplier on Government G-Cloud 13 framework

Congenica is an approved supplier on UK Government G-Cloud 13 framework

Congenica awarded European contract to develop NGS analysis workflow in oncology

Congenica awarded European contract to develop NGS analysis workflow in oncology

Congenica awarded a contract to develop standardised NGS workflows in oncology for a group of 7 Central European hospitals by the Medical University Graz

The Real Costs of Rare Disease

The Real Costs of Rare Disease

Congenica welcomed an expert panel to discuss the true cost of rare disease, from birth to diagnosis, childhood to adulthood.

Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems

Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems

Congenica and FDB announce a collaboration agreement to develop the delivery of pharmacogenomics (PGx) results into point of care prescribing.      

Genomics in South Africa

Genomics in South Africa

A personal view of Genomics in South Africa by Diane May, mother to Matthew who has been diagnosed with Morquio syndrome.